Bioworld Financial Watch articles from June 2006

Bioworld Financial Watch archives from June 2006

Cubicin's new label draws mixed reviews from street.(Antibiotic Still Growing Strong)
June 5, 2006... Cubist Pharmaceuticals Inc.'s stock zoomed late last month on word of the label expansion for its antibiotic Cubicin, but enthusiasm is waning as observers consider the compound's chances more carefully. "In the infectious disease...

10 biggest U.S. gainers for the week.
June 5, 2006... 10 BIGGEST U.S. GAINERS FOR THE WEEK Advancis Pharma (By Dollars) GTC Biothera 81.00 Aspreva 3.31 Encysive Pharma 29.05 IDEXX Laboratories 3.12 Boston Life Sci 25.00...

10 biggest U.S. losers for the week.
June 5, 2006... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) (By Dollars) Oxis Intl. -20.00 Cubist Pharmaceuticals -2.22 Northwest Biothera -16.13 Sepracor -1.74 Insite Vision -14.50...

Collaboration between Biotech and Pharmaceutical Companies: April 27 - May 31, 2006 #.
June 5, 2006... Collaborations Between Biotech And Pharmaceutical Companies: April 27 - May 31, 2006# Biotech Co.* Pharma Co. Type/Product Area (Country; (Country) Symbol) Abraxis AstraZeneca 5.5-year deal to...

Manufacturing, marketing and distribution agreements between Biotech and Pharmaceutical Companies: April 27 - May 31, 2006 #.
June 5, 2006... Manufacturing, Marketing And Distribution Agreements Between Biotech And Pharmaceutical Companies: April 27 - May 31, 2006# Biotech Co.* Pharma Co. Product (Country; (Country) Symbol) ExonHit ...

Biotech--big pharma collaborations: modified and terminated agreements, April 27 - May 31, 2006 #.
June 5, 2006... Biotech-Big Pharma Collaborations: Modified And Terminated Agreements, April 27 - May 31, 2006# I. MODIFIED AGREEMENTS Biotech Co.* Pharma Co. Change from original (Country; (Country) agreement...

BioWorld stock report for public Biotechnology Companies.
June 5, 2006... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close % Change Vol 5/26 6/2 WK YTD (000) Aastrom Biosci ASTM 1.36 ...

ASCO pharma news rivals biotech avalanche of data.(Multi-Kinases, mTORs Among The Stars)(American Society of Clinical Oncology)
June 12, 2006... Players big and small contributed to a slew of news from last week's meeting in Atlanta of the American Society of Clinical Oncology, as the much-attended event kept analysts hopping and provided still more hope for patients. Major pharma...

10 Biggest U.S. gainers for the week.(Statistical table)(Brief article)
June 12, 2006... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Genelabs Techno 160.53 Miravant Medical 50.00 Aeolus Pharma 41.67 NitroMed 28.07 Oxis Intl. 25.00 Transgenomic ...

10 Biggest U.S. losers for the week.
June 12, 2006... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Acusphere -33.98 Discovery Labs -30.88 Aphton -25.00 Clearant -24.53 Avanir -23.76 IDM Pharma ...

Public Financing Of Biotechnology: May 2006.(Statistical table)
June 12, 2006... Public Financing Of Biotechnology: May 2006 I. COMMENCED TRADING IN MAY Company Date Date Shares/ (Symbol) # Filed Comm. Units (M) INITIAL OFFERINGS BioMimetic ...

Other financings of public biotechnology companies: May 2006.(Statistical table)
June 12, 2006... Other Financings Of Public Biotechnology Companies: May 2006 TOTAL: $424.56M Company Type Of Number Of Amount (Symbol) # Financing Shares, Units Raised ...

Venture capital and other investments in private biotechnology companies: May 2006.(Statistical table)
June 12, 2006... Venture Capital And Other Investments In Private Biotechnology Companies: May 2006 FINANCING OF PRIVATE BIOTECHNOLOGY COMPANIES: $511.57M Company Location Date Amt. (M) Aerovance Berkeley, ...

Milestone payments from corporate partners: May 2006.(Statistical data)
June 12, 2006... Milestone Payments From Corporate Partners: May 2006 TOTAL: $40.39M Year to Date: $409.67M Company Partner Amt. Triggering (Symbol) # * Country) (M) Event Acrux Ltd. Elanco...

Money raised by biotech in 2006: January-May.(Statistical table)(Brief article)
June 12, 2006... Money Raised By Biotech In 2006: January-May Type of January February March financing Public offerings $542.2 487 922.3 Private biotechs $476.3 306 $381...

BioWorld stock report for public biotechnology companies.(Statistical table)
June 12, 2006... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close 6/2 6/9 Aastrom Biosci ASTM 1.32 1.24...

Pharma's antibody hunger behind technology buyouts.(An Antibody Trend In M&A)
June 19, 2006... Over the past 12 months or so, the number of freestanding antibody firms has been decreasing, gobbled up mostly by pharma, hungry to establish itself in the very profitable antibody field. It's not just little guys acquired--two of the top...

10 biggest U.S. gainers for the week.(Table)(Brief article)
June 19, 2006... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) Encysive Pharma 24.31 Genzyme 4.05 MacroChem 19.23 Martek Biosciences 2.72 IDM Pharma ...

10 biggest U.S. losers for the week.(Brief article)
June 19, 2006... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) (By Dollars) Immune Response -77.78 Neurocrine Biosci -4.34 Anadys Pharma -24.26 Anadys Pharma -2.21 Neurocrine Biosci ...

FDA submissions, approvals and other actions: May 2006.
June 19, 2006... Clinical Trials Update: May 2006 Company * Product Description (Country; Symbol) AUTOIMMUNE Ocera AST-120 Oral spherical Therapeutics ...

Non-U.S. clinical trials and regulatory actions: May 2006.
June 19, 2006... Non-U.S. Clinical Trials And Regulatory Actions: May 2006 Company * Product Description (Country; Symbol) AUTOIMMUNE BioMS MBP8298 Synthetic peptide Medical Corp. (Canada;...

FDA submissions, approvals and other actions: May 2006.
June 19, 2006... FDA Submissions, Approvals And Other Actions: May 2006 Company * Product Description (Country; Symbol) AUTOIMMUNE Centocor Inc. Remicade Infliximab; monoclonal (unit of Johnson ...

BioWorld stock report for public biotechnology companies.(Table)
June 19, 2006... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close 6/9 6/16 Aastrom Biosci ASTM 1.24 1.2 Acadia Pharma ...

HGS' $165m anthrax score should boost Albuferon Bid.(Human Genome Sciences Inc.'s)
June 26, 2006... Human Genome Sciences Inc.'s $165 million deal with the feds for stockpiling of the anti-anthrax monoclonal antibody ABthrax chalked up headlines for the company--even if it's pretty much a one-shot (pun intended) deal, and HGS' Albuferon bid...

10 Biggest U.S. gainers for the week.(Statistical table)(Brief article)
June 26, 2006... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Access Pharma 80.00 Enzo Biochem 33.61 Generex Biotech 28.57 Insmed 24.82 Sepracor 21.69 Illumina ...

10 Biggest U.S. losers for the week.(Statistical table)(Brief article)
June 26, 2006... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Orchid Biosciences -43.99 Praecis Pharma -39.48 Gene Logic -39.07 Neurocrine Biosci -35.11 Memory Pharma -34.18 Insite Vision ...

Biotech mergers and acquisitions: March 30-June 22, 2006 (#).(Table)
June 26, 2006... Biotech Mergers And Acquisitions: March 30-June 22, 2006 (#) I. COMPLETED MERGERS AND ACQUISITIONS Company Acquired By Date Acquired * Or Merged With * Announced (Country; Symbol) ...

BioWorld stock report for public biotechnology companies.(Statistical table)
June 26, 2006... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close % Change Vol 6/16 6/23 WK YTD (000) Aastrom Biosci ASTM 1.2 ...